Squadron Capital Management’s CalciMedica CALC Stock Holding History

Squadron Capital Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Buy	+1,244,864	New	+$882K	0.4%	37

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Squadron Capital Management's CALC Position: Q2 2026 in Review

Squadron Capital Management opened a new position in CalciMedica (CALC) in Q2 2026: 1,244,864 shares worth $1.28M. The stake represents 0.4% of the portfolio and ranks #37 among its holdings.

31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Squadron Capital Management held 1,244,864 shares of CalciMedica worth $1.28M as of Q2 2026.
CalciMedica was a new Squadron Capital Management position in Q2 2026.
CalciMedica made up 0.4% of Squadron Capital Management's portfolio in Q2 2026, its #37 holding.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Squadron Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.